1. Home
  2. Labeler Index
  3. Gland Pharma Limited
  4. 68083-172
  5. NDC Package Code: 68083-172-01 Deferoxamine Mesylate

NDC Package 68083-172-01 Deferoxamine Mesylate

Injection, Powder, Lyophilized, For Solution Intramuscular; Intravenous; Subcutaneous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
68083-172-01
Package Description:
4 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON
Product Code:
68083-172
Proprietary Name:
Deferoxamine Mesylate
Non-Proprietary Name:
Deferoxamine Mesylate
Substance Name:
Deferoxamine Mesylate
Usage Information:
This medication is used along with other treatments (such as causing vomiting with syrup of ipecac, stomach pumping) to treat sudden iron poisoning. It is most effective when given as soon as possible after the iron was eaten. This medication can also be used to help get rid of iron in patients with high iron levels due to many blood transfusions. Deferoxamine is an iron-binding agent that belongs to a class of drugs known as heavy metal antagonists. It works by helping the kidneys and gallbladder get rid of the extra iron. This medication is not recommended for use in children less than 3 years old (see also Precautions section).
11-Digit NDC Billing Format:
68083017201
NDC to RxNorm Crosswalk:
  • RxCUI: 1731345 - deferoxamine mesylate 2 GM Injection
  • RxCUI: 1731345 - deferoxamine mesylate 2000 MG Injection
  • RxCUI: 1731350 - deferoxamine mesylate 500 MG Injection
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Gland Pharma Limited
    Dosage Form:
    Injection, Powder, Lyophilized, For Solution - A dosage form intended for the solution prepared by lyophilization ("freeze drying"), a process which involves the removal of water from products in the frozen state at extremely low pressures; this is intended for subsequent addition of liquid to create a solution that conforms in all respects to the requirements for Injections.
    Administration Route(s):
  • Intramuscular - Administration within a muscle.
  • Intravenous - Administration within or into a vein or veins.
  • Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
    • Active Ingredient(s):
  • DEFEROXAMINE MESYLATE 500 mg/1
    • Pharmacologic Class(es):
  • Iron Chelating Activity - [MoA] (Mechanism of Action)
  • Iron Chelator - [EPC] (Established Pharmacologic Class)
    • Sample Package:
    No
    FDA Application Number:
    ANDA207384
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    10-09-2017
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 68083-172-01?

    The NDC Packaged Code 68083-172-01 is assigned to a package of 4 injection, powder, lyophilized, for solution in 1 carton of Deferoxamine Mesylate, a human prescription drug labeled by Gland Pharma Limited. The product's dosage form is injection, powder, lyophilized, for solution and is administered via intramuscular; intravenous; subcutaneous form.

    Is NDC 68083-172 included in the NDC Directory?

    Yes, Deferoxamine Mesylate with product code 68083-172 is active and included in the NDC Directory. The product was first marketed by Gland Pharma Limited on October 09, 2017 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 68083-172-01?

    The 11-digit format is 68083017201. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-268083-172-015-4-268083-0172-01